Skip to main content

Telix Pharmaceuticals Ltd

For the period ended Dec 31, 2024. Filed Feb 24, 2025.

View on SEC.gov

About this filing

The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.

FY2024 · Filed Feb 24, 2025

TLX$9.63+2.2%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

CODE OF ETHICS

ITEM 16B.CODE OF ETHICS

We have adopted a Code of Conduct applicable to all of our directors, officers, employees, consultants and contractors to the Telix Group. Our Code of Conduct is publicly available on our website at www.telixpharma.com. We post on our website all disclosures that are required by law, the ASX Listing Rules or the Nasdaq Listing Rules concerning any amendments to, or waivers from, any provision of the Code of Conduct.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.